The human gastrointestinal tract harbors a complex community of microorganisms known as the gut microbiota, which plays a crucial role in maintaining health and regulating various physiological processes. Recent research has highlighted the importance of the gut microbiota in the pathogenesis and progression of pancreatic diseases, including pancreatitis and pancreatic cancer. Fecal Microbiota Transplantation (FMT), a procedure that involves transferring fecal material from a healthy donor to a recipient, has emerged as a potential therapeutic approach for modulating the gut microbiota and treating pancreatic diseases. This article explores the role of the gut microbiota in pancreatic diseases and the potential applications of FMT in their management.
HTML PDFShare this article
Transplantation Technologies & Research received 223 citations as per Google Scholar report
